Interní Med. 2004; 6(4): 211-213

Léčba subarachnoideálního krvácení pomocí NovoSeven

MUDr. Antonín Hluší1, doc. MUDr. Věra Krčová CSc1, MUDr. Andrea Bártková2, MUDr. Bohdan Křupka Ph.D3, MUDr. Jana Zahálková Ph.D4
1 Hemato-onkologická klinika FN a LF UP v Olomouci
2 Neurologická klinika FN a LF UP Olomouc
3 Neurologické oddělení, Vsetínská nemocnice a.s
4 III. interní klinika FN a LF UP Olomouc

Published: December 31, 2004  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Hluší A, Krčová V, Bártková A, Křupka B, Zahálková J. Léčba subarachnoideálního krvácení pomocí NovoSeven. Interní Med. 2004;6(4):211-213.

V článku představujeme novou léčebnou možnost v přístupu k těžkým, život ohrožujícím krvácením. Vlastní zkušenost s preparátem NovoSeven popisujeme u případu úspěšné léčby subarachnoideálního krvácení.

Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Eikelboom JW. Recombinant activated factor VII for the treatment of life-threatening haemorrhage. Blood Coagul Fibrinolysis (2003); 14 (8); S713-717. Go to original source... Go to PubMed...
    2. Erhardtsen E. Ongoing NovoSeven trials. Intensive Care Med (2002); 28; S248-255. Go to original source... Go to PubMed...
    3. Hedner U. Recombinant activated factor VII as a universal haemostatic agent. Blood Coagul Fibrinolysis (1998); 9 (Suppl 1); S147-152.
    4. Martinowitz U. et al. Recombinant activated factor VII for adjunctive hemorrhage control in trauma. J Trauma (2001); 51; S431-438. Go to original source... Go to PubMed...
    5. Mayer SA. Intracerebral hemorrhage: natural history and rationale of ultra-early hemostatic therapy. Intensive Care Med (2002); 28; S235-240. Go to original source... Go to PubMed...

    Return to the content


    Internal Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.